As mentioned before, we have shown previously that IM-R and PD-R CML cells exhibited persistent activation of a Fyn/ERK module that participates to TKI-resistance [20]. The gene discussed is FYN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.